Effects of once-daily extended release quetiapine fumarate on patient-reported outcomes in patients with generalized anxiety disorder

di Endicott, Jean, Svedsäter, Henrik, Locklear, Julie C
Pubblicazione 2012

Ease of use of the ELLIPTA dry powder inhaler: data from three randomised controlled trials in patients with asthma

di Svedsater, Henrik, Jacques, Loretta, Goldfrad, Caroline, Bleecker, Eugene R
Pubblicato in NPJ Prim Care Respir Med (2014)

Qualitative assessment of attributes and ease of use of the ELLIPTA™ dry powder inhaler for delivery of maintenance therapy for asthma and COPD

di Svedsater, Henrik, Dale, Peter, Garrill, Karl, Walker, Richard, Woepse, Mark W
Pubblicazione 2013

Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups

di Svedsater, Henrik, Roberts, June, Patel, Chloe, Macey, Jake, Hilton, Emma, Bradshaw, Lisa
Pubblicato in Adv Ther (2017)

Patients with Asthma Prescribed Once-Daily Fluticasone Furoate/Vilanterol or Twice-Daily Fluticasone Propionate/Salmeterol as Maintenance Treatment: Analysis from a Claims Database

di Atsuta, Ryo, Takai, Jun, Mukai, Isao, Kobayashi, Akihiro, Ishii, Takeo, Svedsater, Henrik
Pubblicato in Pulm Ther (2018)

Evaluating the Impact and Benefits of Fluticasone Furoate/Vilanterol in Individuals with Asthma or COPD: A Mixed-Methods Analysis of Patient Experiences

di Svedsater, Henrik, Doll, Helen A., Macey, Jake, Miles, Gail, Bradshaw, Lisa, Vanya, Magdalena
Pubblicato in Adv Ther (2018)

Modelling the effect of beliefs about asthma medication and treatment intrusiveness on adherence and preference for once-daily vs. twice-daily medication

di Chapman, Sarah, Dale, Peter, Svedsater, Henrik, Stynes, Gillian, Vyas, Nicola, Price, David, Horne, Rob
Pubblicato in NPJ Prim Care Respir Med (2017)

Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes

di Doward, Lynda, Svedsater, Henrik, Whalley, Diane, Crawford, Rebecca, Leather, David, Lay-Flurrie, James, Bosanquet, Nick
Pubblicato in NPJ Prim Care Respir Med (2017)

Follow-up interviews from The Salford Lung Study (COPD) and analyses per treatment and exacerbations

di Whalley, Diane, Svedsater, Henrik, Doward, Lynda, Crawford, Rebecca, Leather, David, Lay-Flurrie, James, Bosanquet, Nick
Pubblicato in NPJ Prim Care Respir Med (2019)

Can medicines development improve outcomes in asthma and chronic obstructive pulmonary disease management by driving effectiveness?

di Leather, David A., Yates, Louisa, Svedsater, Henrik, Jacques, Loretta, Collier, Susan, Powell, Danielle, Jones, Rupert
Pubblicato in Respir Res (2019)

A descriptive follow-up interview study assessing patient-centred outcomes: Salford Lung Study in Asthma (SLS Asthma)

di Doward, Lynda, Svedsater, Henrik, Whalley, Diane, Crawford, Rebecca, Leather, David, Lay-Flurrie, James, Bosanquet, Nick
Pubblicato in NPJ Prim Care Respir Med (2019)

Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma

di Vallejo-Aparicio, Laura Amanda, Molina, Jesús, Ojanguren, Iñigo, Viejo Casas, Ana, Huerta, Alicia, Svedsater, Henrik
Pubblicato in Eur J Health Econ (2019)

Relationship between the Asthma Control Test (ACT) and other outcomes: a targeted literature review

di van Dijk, Bas C. P., Svedsater, Henrik, Heddini, Andreas, Nelsen, Linda, Balradj, Janita S., Alleman, Cathelijne
Pubblicato in BMC Pulm Med (2020)

Correction to: Cost–consequence analysis of fluticasone furoate/vilanterol for asthma management in Spain: an analysis based on the Salford Lung Study in asthma

di Vallejo-Aparicio, Laura Amanda, Molina, Jesús, Ojanguren, Iñigo, Viejo Casas, Ana, Huerta, Alicia, Svedsater, Henrik
Pubblicato in Eur J Health Econ (2019)

Once-daily fluticasone furoate/vilanterol 100/25 mcg versus twice daily combination therapies in COPD – mixed treatment comparisons of clinical efficacy

di Stynes, Gillian, Svedsater, Henrik, Wex, Jaro, Lettis, Sally, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
Pubblicato in Respir Res (2015)

Once-daily fluticasone furoate/vilanterol versus twice daily combination therapies in asthma–mixed treatment comparisons of clinical efficacy

di Svedsater, Henrik, Stynes, Gillian, Wex, Jaro, Frith, Lucy, Leather, David, Castelnuovo, Emanuela, Detry, Michelle, Berry, Scott
Pubblicato in Asthma Res Pract (2016)

Persistence and Adherence to ICS/LABA Drugs in UK Patients with Asthma: A Retrospective New-User Cohort Study

di Parimi, Mounika, Svedsater, Henrik, Ann, Quratul, Gokhale, Mugdha, Gray, Christen M., Hinds, David, Nixon, Mark, Boxall, Naomi
Pubblicato in Adv Ther (2020)

Impact of socioeconomic status on participation and outcomes in the Salford Lung Studies

di Jones, Rupert, Nicholls, Andy, Browning, Dominy, Diar Bakerly, Nawar, Woodcock, Ashley, Vestbo, Jørgen, Leather, David A., Jacques, Loretta, Lay-Flurrie, James, Svedsater, Henrik, Collier, Susan
Pubblicato in ERJ Open Res (2020)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inh...

di van der Palen, Job, Thomas, Mike, Chrystyn, Henry, Sharma, Raj K, van der Valk, Paul DLPM, Goosens, Martijn, Wilkinson, Tom, Stonham, Carol, Chauhan, Anoop J, Imber, Varsha, Zhu, Chang-Qing, Svedsater, Henrik, Barnes, Neil C
Pubblicato in NPJ Prim Care Respir Med (2016)

A randomised open-label cross-over study of inhaler errors, preference and time to achieve correct inhaler use in patients with COPD or asthma: comparison of ELLIPTA with other inh...

di van der Palen, Job, Thomas, Mike, Chrystyn, Henry, Sharma, Raj K, van der Valk, Paul DLPM, Goosens, Martijn, Wilkinson, Tom, Stonham, Carol, Chauhan, Anoop J, Imber, Varsha, Zhu, Chang-Qing, Svedsater, Henrik, Barnes, Neil C
Pubblicato in NPJ Prim Care Respir Med (2017)